investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
+
-
Project leads
Collaborators
In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs
James C Paulson
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Weihsu Claire Chen
Ontario Institute for Cancer Research
Toronto, Canada
James C Paulson
Scripps Research Institute
San Diego, United States
Related projects
Saro Armenian
Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma
Non-Hodgkin lymphoma
Hematology and hematologic malignancies
Michael Wang
A Phase II, Multicenter, International Study of Lenalidomide and Rituximab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Non-Hodgkin Lymphoma, Transformed Large Cell Lymphoma, and Grade 3 Follicular Lymphoma
Non-Hodgkin lymphoma
Hematology and hematologic malignancies
Richard Aplenc
Toxicity Monitoring on Phase III Trials with Administrative Data
Leukaemia
Hematology and hematologic malignancies
Jeffrey S Miller
NK Cells, their Receptors and Unrelated Donor Transplant
Leukaemia
Hematology and hematologic malignancies
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Hematology and hematologic malignancies
Carl F Ware
HVEM-BTLA Pathway in Lymphoma
Non-Hodgkin lymphoma
Hematology and hematologic malignancies
Karin L Gaensler
Efficacy and Safety of Novel CD80 IL15 IL15Ra Expressing Autologous AML Vaccines
Leukaemia
Hematology and hematologic malignancies
Thomas J O'Hare
Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia
Leukaemia
Hematology and hematologic malignancies
Corey Casper
Burkitt Lymphoma Trials Network (BLTN)
Non-Hodgkin lymphoma
Hematology and hematologic malignancies
